AN2 Therapeutics, Inc. (NASDAQ:ANTX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joseph S. Zakrzewski Other companies: Cyteir Therapeutics Inc (Director · Jun 17, 2021 – Feb 6, 2024 · Past); Sangamo Therapeutics, Inc. (Director · Jun 26, 2017 – Feb 25, 2022 · Past); LipoScience Inc (Director · Jun 11, 2014 – Nov 20, 2014 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Nov 19, 2021 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Dec 14, 2021 · Past); Insulet Corporation (Director · May 8, 2008 – May 17, 2017 · Past) | Co-Founder · Since at least Mar 24, 2022 |
| Melvin Spigelman Other companies: Synergy Pharmaceuticals Inc (Director · Aug 3, 2011 – Aug 15, 2018 · Past); The Medicines Company (Director · May 25, 2006 – May 25, 2018 · Past) | GATB · Since at least Mar 24, 2022 |
| Stephanie Wong Other companies: Calithera Biosciences, Inc. (See Remarks · Jan 1, 2017 – Jan 23, 2023 · Past); SciClone Pharmaceuticals Inc (VP, Finance and Controller · Aug 3, 2012 – Apr 4, 2013 · Past) | Director · Since at least Mar 24, 2022 |
| Margaret M FitzPatrick Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Jul 21, 2021) | Director · Since at least May 5, 2022 |
| Michael Adrian Nazak Other companies: Aridis Pharmaceuticals Inc. (Chief Financial Officer · Feb 18, 2021 – Feb 18, 2021 · Past) | Chief Accounting Officer · Mar 24, 2022 – Feb 15, 2023 · Past |
| Patricia Martin Other companies: Cypherpunk Technologies Inc. (Director · Since at least Jan 17, 2023) | Director · Since at least May 12, 2022 |
| Cameron C Trenor III | Chief Medical Officer · Since at least Aug 24, 2026 |
| Cameron Trenor | Chief Medical Officer · Since at least Aug 24, 2026 |
| Eric Easom | Co-founder, President, CEO, and Chair · Since at least Oct 20, 2026 |
| Gilbert Lynn Marks | Director · Since at least Mar 24, 2022 |
| Joshua M Eizen | See Remarks · Since at least Sep 29, 2022 |
| Kabeer Aziz | Director · Since at least Mar 24, 2022 |
| Lucy O. Day | Chief Financial Officer · Since at least Mar 24, 2022 |
| Lynn Marks | Senior Vice President (Retired), GlaxoSmithKline · Since at least Nov 5, 2026 |
| Maggie FitzPatrick | Fitzpatrick & Co, Founder & CEO, Lead Independent Director · Since at least Sep 2, 2026 |
| Paul Eckburg | Chief Medical Officer · Mar 24, 2022 – Mar 15, 2024 · Past |
| Robin Shane Readnour | Director · Since at least Mar 24, 2022 |
| Rob Readnour | Managing Director, Mountain Group Partners, Director · Since at least Nov 4, 2026 |
| Sanjay Chanda | Chief Development Officer · Since at least Mar 24, 2022 |
| Sarah Joanne Williams | Principal Accounting Officer · Since at least Jan 26, 2026 |
| Stephen David Prior | Chief Strategy Officer · Since at least Nov 4, 2024 |